(Q38584377)

4 September 2017

title

Testosterone in women--the clinical significance (English)

1 reference

4 September 2017

1 reference

1 reference

1

0 references

author name string

Sarah Wahlin-Jacobsen

series ordinal

2

1 reference

4 September 2017

publication date

7 September 2015

1 reference

The Lancet: Diabetes & Endocrinology

4 September 2017

published in

1 reference

4 September 2017

volume

3

1 reference

4 September 2017

issue

12

1 reference

4 September 2017

page(s)

980-992

1 reference

Is there a correlation between androgens and sexual desire in women?

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Masturbation frequency and sexual function domains are associated with serum reproductive hormone levels across the menopausal transition

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Androgen Therapy in Women: A Reappraisal: An Endocrine Society Clinical Practice Guideline

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Clinical review: DHEA replacement for postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatography-tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

The circadian variation in Anti-Müllerian hormone in patients with polycystic ovary syndrome differs significantly from normally ovulating women

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Androgen levels in adult females: changes with age, menopause, and oophorectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Immunoassays for testosterone in women: better than a guess?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Development and validation of a sensitive liquid chromatography-tandem mass spectrometry assay to simultaneously measure androgens and estrogens in serum without derivatization

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Circulating androgen levels and self-reported sexual function in women

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Role of androgens in women's sexual dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Clinical review: The benefits and harms of systemic testosterone therapy in postmenopausal women with normal adrenal function: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Testosterone for low libido in postmenopausal women not taking estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Testosterone for peri and postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Androgen receptor expression in the human vagina under different physiological and treatment conditions

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Correlation of androgen receptors, aromatase, and 5-alpha reductase in the human vagina with menopausal status

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Proliferative effect of testosterone propionate on human vaginal epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

A comparative study of the effects of local estrogen with or without local testosterone on vulvovaginal and sexual dysfunction in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on sexual function in postmenopausal women: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Topical testosterone for breast cancer patients with vaginal atrophy related to aromatase inhibitors: a phase I/II study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Androgens and cardiovascular disease in postmenopausal women: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

The influence of testosterone upon vascular reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Endogenous testosterone and endothelial function in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Mechanisms involved in testosterone-induced vasodilatation in pig prostatic small arteries

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

The relationship between sex hormones, sex hormone binding globulin and peripheral artery disease in older persons

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Endogenous androgens and carotid intimal-medial thickness in women

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Endogenous postmenopausal hormones and carotid atherosclerosis: a case-control study of the atherosclerosis risk in communities cohort

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Sex hormone levels and subclinical atherosclerosis in postmenopausal women: the Multi-Ethnic Study of Atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Prospective association of serum androgens and sex hormone-binding globulin with subclinical cardiovascular disease in young adult women: the "Coronary Artery Risk Development in Young Adults" women's study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Endogenous sex hormone levels in postmenopausal women undergoing carotid artery endarterectomy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Endogenous steroids measured by high-specificity liquid chromatography-tandem mass spectrometry and prevalent cardiovascular disease in 70-year-old men and women

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Low testosterone levels predict all-cause mortality and cardiovascular events in women: a prospective cohort study in German primary care patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Extremes of endogenous testosterone are associated with increased risk of incident coronary events in older women

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

High level of plasma estradiol as a new predictor of ischemic arterial disease in older postmenopausal women: the three-city cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Extreme concentrations of endogenous sex hormones, ischemic heart disease, and death in women.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Age-specific reference ranges for serum testosterone and androstenedione concentrations in women measured by liquid chromatography-tandem mass spectrometry.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Sex hormone-binding globulin and risk of type 2 diabetes in women and men

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Relationships of circulating sex hormone-binding globulin with metabolic traits in humans

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

The contribution of SHBG to the variation in HOMA-IR is not dependent on endogenous oestrogen or androgen levels in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Endogenous estrogen and androgen levels are not independent predictors of lipid levels in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Testosterone and visceral fat in midlife women: the Study of Women's Health Across the Nation (SWAN) fat patterning study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Sex hormone-binding globulin gene expression in the liver: drugs and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Glucose and insulin components of the metabolic syndrome are associated with hyperandrogenism in postmenopausal women: the atherosclerosis risk in communities study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Production of Proinflammatory Cytokines and Chemokines During Neuroinflammation: Novel Roles for Estrogen Receptors α and β

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Estradiol and testosterone in specific regions of the human female brain in different endocrine states

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Protective actions of sex steroid hormones in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

A single administration of testosterone improves visuospatial ability in young women

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Effects of testosterone administration on selective aspects of object-location memory in healthy young women.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Associations between circulating sex steroid hormones and cognition in normal elderly women.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Endogenous estradiol and testosterone levels are associated with cognitive performance in older women and men.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Administration of testosterone undecanoate in postmenopausal women: effects on androgens, estradiol, and gonadotrophins

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

A randomized trial of the effect of testosterone and estrogen on verbal fluency, verbal memory, and spatial ability in healthy postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Effects of testosterone and estrogen replacement on memory function

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Continuous-combined oral estradiol/drospirenone has no detrimental effect on cognitive performance and improves estrogen deficiency symptoms in early postmenopausal women: a randomized placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Testosterone improves verbal learning and memory in postmenopausal women: Results from a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Transdermal testosterone improves verbal learning and memory in postmenopausal women not on oestrogen therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

The role of aromatization in testosterone supplementation: effects on cognition in older men.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Testosterone aromatization and cognition in women: a randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

1 reference

7 January 2021

Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Higher serum free testosterone concentration in older women is associated with greater bone mineral density, lean body mass, and total fat mass: the cardiovascular health study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Associations of serum sex hormone-binding globulin and sex hormone concentrations with hip fracture risk in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Bone mineral density in young women with primary ovarian insufficiency: results of a three-year randomized controlled trial of physiological transdermal estradiol and testosterone replacement

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Epidemiology of breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Cardiovascular and cancer safety of testosterone in women.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Testosterone effects on the breast: implications for testosterone therapy for women.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Steroid hormone measurements from different types of assays in relation to body mass index and breast cancer risk in postmenopausal women: Reanalysis of eighteen prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Aromatase expression in women's cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Adipose aromatase gene expression is greater in older women and is unaffected by postmenopausal estrogen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

The role of local estrogen biosynthesis in males and females

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Combined Estrogen and Testosterone Use and Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Postmenopausal estrogen-containing hormone therapy and the risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Influence of estrogen plus testosterone supplementation on breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Breast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

The incidence of invasive breast cancer among women prescribed testosterone for low libido.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Reduced breast cancer incidence in women treated with subcutaneous testosterone, or testosterone with anastrozole: a prospective, observational study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Endogenous androgens and risk of epithelial invasive ovarian cancer by tumor characteristics in the European Prospective Investigation into Cancer and Nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Effect of long-term testosterone administration on the endometrium of female-to-male (FtM) transsexuals

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

Intrinsa fails to impress FDA advisory panel

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

The 5 alpha-reductase system and its inhibitors. Recent development and its perspective in treating androgen-dependent skin disorders

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900284-3

7 January 2021

10.1016/S2213-8587(15)00284-3

Identifiers

DOI

1 reference

4 September 2017

1 reference